Stonepine Capital Management as of Dec. 31, 2020
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 21 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Com New (LGND) | 24.8 | $32M | 326k | 99.45 | |
| Amryt Pharma Ltd - Spnr Sponsored Ads | 15.4 | $20M | 1.4M | 14.16 | |
| Diamedica Therapeutics Com New (DMAC) | 7.4 | $9.6M | 950k | 10.14 | |
| Aytu Bioscience | 6.4 | $8.4M | 1.4M | 5.98 | |
| Apollo Endosurgery | 6.1 | $7.9M | 2.3M | 3.40 | |
| Cti Biopharma | 5.1 | $6.6M | 2.1M | 3.22 | |
| Iveric Bio | 4.2 | $5.5M | 800k | 6.91 | |
| Xoma Corp Com New (XOMA) | 4.2 | $5.5M | 124k | 44.13 | |
| Catalyst Biosciences Com New | 4.0 | $5.3M | 834k | 6.31 | |
| Scynexis Com New (SCYX) | 4.0 | $5.2M | 685k | 7.65 | |
| Adamas Pharmaceuticals | 2.7 | $3.5M | 808k | 4.33 | |
| Strongbridge Biopharma Shs Usd | 2.5 | $3.3M | 1.4M | 2.43 | |
| Gamida Cell SHS (GMDA) | 2.4 | $3.2M | 380k | 8.39 | |
| Chiasma | 2.4 | $3.1M | 721k | 4.35 | |
| Neos Therapeutics | 2.4 | $3.1M | 5.0M | 0.62 | |
| Tokai Pharmaceuticals | 2.0 | $2.6M | 167k | 15.40 | |
| Yumanity Therapeutics | 1.4 | $1.8M | 109k | 17.00 | |
| Affimed Therapeutics B V | 1.0 | $1.3M | 219k | 5.82 | |
| Vistagen Therapeutics Com New | 0.7 | $970k | 500k | 1.94 | |
| Aptevo Therapeutics Com New | 0.5 | $670k | 18k | 36.65 | |
| Cumberland Pharmaceuticals (CPIX) | 0.4 | $557k | 189k | 2.95 |
